Candidate luminal B breast cancer genes identified by genome, gene expression and DNA methylation profiling.
Breast cancers (BCs) of the luminal B subtype are estrogen receptor-positive (ER+), highly proliferative, resistant to standard therapies and have a poor prognosis. To better understand this subtype we compared DNA copy number aberrations (CNAs), DNA promoter methylation, gene expression profiles, a...
Збережено в:
| Автори: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Public Library of Science (PLoS)
2014-01-01
|
| Серія: | PLoS ONE |
| Онлайн доступ: | http://europepmc.org/articles/PMC3886975?pdf=render |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
